Ultragenyx Pharmaceutical | RARE - Efectivo Y Equivalentes

Precio De Mercado
19.87
Cambio Diario
-0.55 -2.69%
Mensual
-11.73%
Anual
-49.29%
Q1 Expectativa
19.27




Efectivo Y Equivalentes Cambio Fecha
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
Agios Pharmaceuticals USD 89.13M 3.58M 2025-12
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
BioCryst Pharmaceuticals USD 335.91M 251.83M 2025-12
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Esperion Therapeutics USD 92.45M 6.39M 2025-09
Immunic USD 35.13M 20.18M 2025-09
Insmed USD 510.44M 175.68M 2025-12
Ionis Pharmaceuticals USD 2.68B 437M 2025-12
Karyopharm Therapeutics USD 37.67M 1.05M 2025-09
Kyowa Hakko Kirin JPY 234.6B 20.23B 2025-06
MacroGenics USD 57.22M 22.91M 2025-12
Moderna USD 2.6B 1.46B 2025-12
Neurocrine Biosciences USD 713M 372.8M 2025-12
PTC Therapeutics USD 984.65M 312.03M 2025-12
Puma Biotechnology USD 53.52M 1.14M 2025-09
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12
Xoma USD 143.9M 7.68M 2024-06